Related Experiment Video
Updated: Jan 1, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Decrease in the proportion of CD24hi CD38hi B cells and impairment of their regulatory capacity in type 1 diabetes
1Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China.
Insights
B10 cells, crucial for immune balance, are deficient in type 1 diabetes (T1D). This study reveals lower numbers and impaired function of these regulatory B cells in T1D patients, contributing to immune dysregulation in the disease.
Area of Science:
- Immunology
- Endocrinology
- Autoimmunity
Background:
- B10 cells are vital for maintaining immune homeostasis through interleukin-10 (IL-10) production.
- Dysfunctional B10 cells are implicated in various autoimmune diseases, but their role in type 1 diabetes (T1D) remains debated.
- This study investigates potential numerical and functional defects of B10 cells in T1D patients.
Purpose of the Study:
- To determine the frequency and function of B10 cells in patients with type 1 diabetes (T1D).
- To investigate the regulatory capacity of CD24hi CD38hi B cells in healthy individuals and T1D patients.
- To explore the correlation between B10 cell levels and T cell subsets in T1D.
Main Methods:
- Flow cytometry was used to identify and quantify B10 cells (CD24hi CD38hi B cells) in peripheral blood.
- Functional assays assessed the regulatory capacity of B10 cells in suppressing pro-inflammatory cytokine production (IFN-γ, TNF-α, IL-17A) and promoting regulatory T cell markers (IL-4, FoxP3).
- Statistical analyses, including Pearson's correlation, were employed to examine relationships between B10 cell frequency and T cell populations.
Main Results:
- B10 cells were identified as a CD24hi CD38hi B cell subpopulation in human peripheral blood.
- Healthy individuals' B10 cells exhibited regulatory capacity, suppressing IFN-γ, TNF-α, and IL-17A while promoting IL-4 and FoxP3 expression in T cells via IL-10.
- T1D patients showed significantly lower percentages of B10 cells, reduced IL-10 production, and impaired regulatory function compared to healthy controls.
- A negative correlation was observed between circulating B10 cell frequency and pro-inflammatory CD4+ T cells (IFN-γ+, TNF-α+), and a positive correlation with regulatory CD4+ T cells (CD25+, FoxP3+).
Conclusions:
- Patients with T1D exhibit a deficiency in circulating CD24hi CD38hi B cells (B10 cells).
- These B10 cell defects contribute to immune imbalance and may play a role in the pathogenesis of type 1 diabetes.
- Restoring B10 cell function could be a potential therapeutic strategy for T1D.
Abstract:
B10 cells restore immune balance by producing interleukin (IL)-10. Impaired B10 cell responses are related to numerous autoimmune diseases. However, the function of B10 cells in type 1 diabetes (T1D) patients is controversial. We hypothesized that there are numerical and functional defects of B10 cells in T1D. Sixty-two patients with T1D and 74 healthy volunteers were included in our study. We showed that B10 cells in human peripheral blood belong to a CD24hi CD38hi B cell subpopulation. CD24hi CD38hi B cells from healthy individuals possessed regulatory capacity, suppressed interferon (IFN)-γ, tumor necrosis factor (TNF)-α and IL-17A production and promoted IL-4 production and forkhead box protein 3 (FoxP3) expression in CD4+ T cells through an IL-10-dependent mechanism. Compared to healthy controls, B10 cell percentages in T1D were significantly lower (5·6 ± 3·5 versus 6·9 ± 3·3%; P < 0·05), produced less IL-10 (15·4 ± 4·3 versus 29·0 ± 4·5%; P < 0·001) and lacked regulatory capacity. In addition, Pearson's correlation analysis showed that the frequency of circulating B10 cells was negatively correlated with the frequency of CD4+ IFN-γ+ and CD4+ TNF-α+ T cells (r = -0·248 and r = -0·283, P = 0·008 and P = 0·017, respectively), positively correlating with the frequency of CD4+ CD25+ FoxP3+ T cells (r = 0·247, P = 0·001). These data offer direct proof that there is a deficiency of circulating CD24hi CD38hi B cells in peripheral blood of patients with T1D, which participate in the T1D immune imbalance involved in the development of T1D.
More Related Videos
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
08:06Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow Cytometry
Published on: February 27, 2019
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Psychoneuroimmunology: Diabetes and Cancer